Hospitals Slam GAO Finding That 340B Drug Discounts Fuel Prescribing

July 7, 2015

Modern Healthcare (Dickson) reported that hospital associations have questioned the methodology of a U.S. Government Accountability Office (GAO) report that found that “per beneficiary Medicare Part B drug spending … was substantially higher at hospitals utilizing the 340B discount than other hospitals. … They feel the report doesn’t take into account that 340B hospitals may see sicker patients than other hospitals and noted that the GAO may have unfairly ignored other reasons for the higher spending including the fact that patients of non-340B hospitals more frequently receive drugs in non-hospital settings.” The U.S. Department of Health and Human Services also raised concerns, stating that the report did not take into account “patient differences in terms of outcomes or quality.”